Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults GlobeNewswire
Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults. Study conducted in the United-States …
Source:: Oakland, California News By Google News